367 related articles for article (PubMed ID: 11265139)
41. Detection of human papillomavirus types 16 and 18 in primary and in metastatic lesions of cervical carcinomas.
Mvula M; Iwasaka T; Matsuo N; Nakao Y; Kaku T; Hachisuga T; Fukuda K; Tsukamoto N; Sugimori H
Gynecol Oncol; 1994 May; 53(2):156-60. PubMed ID: 8188074
[TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring.
Paz IB; Cook N; Odom-Maryon T; Xie Y; Wilczynski SP
Cancer; 1997 Feb; 79(3):595-604. PubMed ID: 9028373
[TBL] [Abstract][Full Text] [Related]
44. Cytomegalovirus and cervical cancer: failure to detect a direct association or an interaction with human papillomaviruses.
Thompson CH; Rose BR; Elliott PM
Gynecol Oncol; 1994 Jul; 54(1):40-6. PubMed ID: 8020838
[TBL] [Abstract][Full Text] [Related]
45. [Prognostic value of human papilloma virus DNA test in patients surgically treated for squamous cell cervical cancer].
Bakhidze EV; Lavrinovich OE; Chepik OF; Kiselev OI
Vopr Onkol; 2012; 58(2):233-7. PubMed ID: 22774530
[TBL] [Abstract][Full Text] [Related]
46. Genomic organization of human papillomavirus type 18 in cervical cancer specimens.
Kitagawa K; Yoshikawa H; Onda T; Kawana T; Taketani Y; Yoshikura H; Iwamoto A
Jpn J Cancer Res; 1996 Mar; 87(3):263-8. PubMed ID: 8613428
[TBL] [Abstract][Full Text] [Related]
47. HPV- and node status in cervical cancer long-term results.
Póka R; Czeglédy J
Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):169-72. PubMed ID: 9138961
[TBL] [Abstract][Full Text] [Related]
48. HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer.
van Bommel PF; van den Brule AJ; Helmerhorst TJ; Gallee MP; Gaarenstroom KN; Walboomers JM; Meijer CJ; Kenemans P
Gynecol Oncol; 1993 Mar; 48(3):333-7. PubMed ID: 8385059
[TBL] [Abstract][Full Text] [Related]
49. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
[TBL] [Abstract][Full Text] [Related]
50. The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Menso S; De Nictolis M; Romanini C; Biagini G
Cancer; 1998 Mar; 82(5):886-92. PubMed ID: 9486578
[TBL] [Abstract][Full Text] [Related]
51. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing.
Andersson S; Rylander E; Larson B; Sigurdardottir S; Backlund I; Sällström J; Wilander E
Oncol Rep; 2003; 10(1):175-9. PubMed ID: 12469166
[TBL] [Abstract][Full Text] [Related]
52. Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues.
Huang LW; Chao SL; Chen PH; Chou HP
J Clin Virol; 2004 Apr; 29(4):271-6. PubMed ID: 15018855
[TBL] [Abstract][Full Text] [Related]
53. Correlation of human papillomavirus 16 and 18 with cervical neoplasia in histological typing and clinical stage in Taiwan: an in-situ polymerase chain reaction approach.
Shyu JS; Chen CJ; Chiu CC; Huang SC; Harn HJ
J Surg Oncol; 2001 Oct; 78(2):101-9. PubMed ID: 11579387
[TBL] [Abstract][Full Text] [Related]
54. Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers.
Lo KW; Cheung TH; Chung TK; Wang VW; Poon JS; Li JC; Lam P; Wong YF
Gynecol Obstet Invest; 2001; 51(3):202-7. PubMed ID: 11306910
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancer.
Burnett AF; Barnes WA; Johnson JC; Grendys E; Willett GD; Barter JF; Doniger J
Gynecol Oncol; 1992 Dec; 47(3):343-7. PubMed ID: 1335431
[TBL] [Abstract][Full Text] [Related]
57. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
58. Can recurrence of cervical cancer be predicted by human papillomavirus DNA in nodes or plasma?
Peedicayil A; Sathish N; Gnanamony M; John S; Viswanathan FR; Naseema PS; Abraham P
J Low Genit Tract Dis; 2009 Apr; 13(2):102-6. PubMed ID: 19387130
[TBL] [Abstract][Full Text] [Related]
59. Extralesional detection and load of human papillomavirus DNA: a possible marker of preclinical tumor spread in cervical cancer.
Lillo F; Galli L; Lodini S; Taccagni G; Ferrari A; Origoni M
J Low Genit Tract Dis; 2008 Jul; 12(3):204-9. PubMed ID: 18596462
[TBL] [Abstract][Full Text] [Related]
60. Human papillomavirus and mutated H-ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: a retrospective follow-up.
Landro ME; Dalbert D; Picconi MA; Cúneo N; González J; Vornetti S; Bazán G; Mural J; Basiletti J; Teyssié AR; Alonio LV
J Med Virol; 2008 Apr; 80(4):694-701. PubMed ID: 18297710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
